News from valeant pharmaceuticals international, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 25, 2015, 08:00 ET Valeant Pharmaceuticals Announces The Addition Of D. Robert Hale To Its Board Of Directors

Jeffery W. Ubben Has Resigned From Board  Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced the addition...


Aug 20, 2015, 07:28 ET Valeant Pharmaceuticals To Acquire Sprout Pharmaceuticals

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Sprout Pharmaceuticals, Inc. today announced that they have entered into a...


Jun 24, 2015, 08:00 ET Valeant Pharmaceuticals To Announce 2015 Second Quarter Results On July 23, 2015

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet...


Jun 23, 2015, 09:15 ET Valeant and Progenics Announce the Submission of U.S. New Drug Application for Oral RELISTOR®

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today...


Jun 12, 2015, 08:40 ET ValueAct Capital desvela la venta de acciones de Valeant Pharmaceuticals International, Inc.

 ValueAct Capital Management, L.P. anunció hoy que ha vendido 4,2 millones de acciones de Valeant Pharmaceuticals International, Inc....


Jun 12, 2015, 08:26 ET ValueAct Capital gibt Verkauf von Anteilen an Valeant Pharmaceuticals International, Inc. bekannt

 ValueAct Capital Management, L.P. verkündete heute den Verkauf von 4,2 Millionen Aktien von Valeant Pharmaceuticals International, Inc....


Jun 12, 2015, 07:21 ET ValueAct Capital annonce la vente d'actions de Valeant Pharmaceuticals International, Inc.

 ValueAct Capital Management, L.P. a annoncé ce jour avoir vendu 4,2 millions d'actions de Valeant Pharmaceuticals International,...


Jun 11, 2015, 09:28 ET ValueAct Capital Discloses Sale of Shares of Valeant Pharmaceuticals International, Inc.

 ValueAct Capital Management, L.P. announced today that it has sold 4.2 million shares of Valeant Pharmaceuticals International, Inc. (NYSE:...


Jun 11, 2015, 09:00 ET Valeant Pharmaceuticals To Appoint Robert L. Rosiello As Chief Financial Officer

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that Robert L. Rosiello was appointed as Executive Vice...


May 27, 2015, 17:59 ET Salix Announces FDA Approval of Xifaxan® 550 mg for the Treatment of IBS-D (Irritable Bowel Syndrome with Diarrhea)

Xifaxan® 550 mg is the first-and-only nonsystemic antibiotic approved for the treatment of IBS-D in adults  Valeant Pharmaceuticals...


May 19, 2015, 17:00 ET Valeant Pharmaceuticals Announces 2015 Annual Meeting Results

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced the election of eleven directors nominated at its 2015...


May 12, 2015, 16:05 ET Valeant Pharmaceuticals To Webcast 2015 Annual Meeting Of Shareholders

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will conduct a live webcast of the company's annual...


Apr 29, 2015, 06:00 ET Valeant Announces CFO Succession Plan And Additional Executive Appointment

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Howard B. Schiller has advised the Company of his decision...


Apr 29, 2015, 06:00 ET Valeant Pharmaceuticals Reports First Quarter 2015 Financial Results

2015 First Quarter Results - Total Revenue $2.2 billion; an increase of 16% over the prior year despite negative foreign exchange impact of...


Apr 24, 2015, 09:14 ET RELISTOR® Receives Positive CHMP Opinion in the EU for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-Cancer Pain

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced...


Apr 09, 2015, 08:00 ET Valeant Pharmaceuticals To Announce 2015 First Quarter Results On April 29, 2015

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast...


Apr 01, 2015, 17:00 ET Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015

 Salix Pharmaceuticals, Ltd. (the "Company" or "Salix"), a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX)...


Apr 01, 2015, 17:00 ET Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019

Salix Pharmaceuticals, Ltd. (the "Company" or "Salix"), a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX)...


Apr 01, 2015, 09:05 ET Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021

 Salix Pharmaceuticals, Ltd. ("Salix"), a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX:VRX), today...


Apr 01, 2015, 09:00 ET Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Salix Pharmaceuticals

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced it has completed the previously announced acquisition of Salix...